Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare Inc. (PBH) Stock Overview

Explore Prestige Consumer Healthcare Inc.’s financial performance, market position, analyst ratings, and future outlook.

PBHNYSE
HealthcareMedical - Distribution
$48.36
$1.17(2.48%)
U.S. Market opens in 6h 10m

Prestige Consumer Healthcare Inc. (PBH)

Meyka AI Score

Z

Key Financials

Market Cap2.3B
P/E Ratio12.21
EPS (TTM)$4.39
ROE0.10%
Fundamental Analysis

AI Price Forecasts

1 Month$43.50
3 Months$28.43
1 Year Target$39.40

PBH Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Prestige Consumer Healthcare Inc. (PBH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.01, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $39.40.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 12.21 and a market capitalization of 2.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.44%
5-Day Change
-0.86%
1-Month Change
3.58%
3-Month Change
-16.03%
6-Month Change
-26.32%
Year-to-Date (YTD) Change
-21.64%
1-Year Change
-35.68%
3-Year Change
-18.37%
5-Year Change
-6.41%
All-Time (Max) Change
172.34%

Contact Information

914 524 6800
660 White Plains Road, Tarrytown, NY, 10591

Company Facts

8,900 Employees
IPO DateFeb 10, 2005
CountryUS
Actively Trading

Frequently Asked Questions